We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+9.18%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$4.39B
AUM Growth
+$118M
Cap. Flow
-$190M
Cap. Flow %
-4.31%
Top 10 Hldgs %
15.83%
Holding
1,464
New
104
Increased
519
Reduced
644
Closed
116

Sector Composition

Rank Sector Weight
1 Technology 15.67%
2 Healthcare 11.79%
3 Financials 11.13%
4 Industrials 8.9%
5 Consumer Discretionary 7.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IAG icon
1326
IAMGOLD
IAG
$10.4B
$36K ﹤0.01%
13,960
+115
+0.8% +$200
NVTA
1327
DELISTED
Invitae Corporation
NVTA
$30.2K ﹤0.01%
16,250
+2,600
+19% +$6.35K
CGEN icon
1328
Compugen
CGEN
$225M
$26.1K ﹤0.01%
36,500
+5,000
+16% +$4.36K
OTLK icon
1329
Outlook Therapeutics
OTLK
$208M
$24.1K ﹤0.01%
1,115
+215
+24% +$4.68K
VBIV
1330
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$23.9K ﹤0.01%
2,037
-1,173
-37% -$20.7K
RGTI icon
1331
Rigetti Computing
RGTI
$6.01B
$22.3K ﹤0.01%
30,587
+5,000
+20% +$7.15K
TELL
1332
DELISTED
Tellurian Inc.
TELL
$21.8K ﹤0.01%
+13,000
New +$32.6K
TOON icon
1333
Kartoon Studios
TOON
$35.1M
$18.1K ﹤0.01%
3,895
-846
-18% -$5.46K
MREO
1334
Mereo BioPharma
MREO
$54.8M
$18K ﹤0.01%
24,000
-2,000
-8% -$1.64K
WRN
1335
Western Copper and Gold
WRN
$551M
$17.8K ﹤0.01%
10,000
DMTK
1336
DELISTED
DermTech, Inc. Common Stock
DMTK
$17.7K ﹤0.01%
+10,000
New +$26.6K
EAR
1337
DELISTED
Eargo, Inc. Common Stock
EAR
$17K ﹤0.01%
1,476
+476
+48% +$6.12K
RVP icon
1338
Retractable Technologies
RVP
$20.1M
$16.4K ﹤0.01%
10,020
MLSS icon
1339
Milestone Scientific
MLSS
$42M
$15.6K ﹤0.01%
32,500
-10,000
-24% -$6.47K
CD
1340
Chaince Digital Holdings
CD
$230M
$14K ﹤0.01%
11,250
AMRN
1341
Amarin Corp
AMRN
$299M
$13.3K ﹤0.01%
+550
New +$13.2K
FIRY
1342
Firy Inc
FIRY
$158M
$11.1K ﹤0.01%
1,093
PVLA
1343
Palvella Therapeutics
PVLA
$2.23B
$10.9K ﹤0.01%
131
SURF
1344
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$8.8K ﹤0.01%
10,733
WATT icon
1345
Energous
WATT
$105M
$8.4K ﹤0.01%
17
-8
-32% -$4.82K
MTEM
1346
DELISTED
Molecular Templates, Inc.
MTEM
$6.56K ﹤0.01%
1,333
+666
+100% +$5.51K
ORTX
1347
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$4.27K ﹤0.01%
1,150
-20
-2% -$88
DMK
1348
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$2.03K ﹤0.01%
171
ADIL
1349
Adial Pharmaceuticals
ADIL
$9.24M
-62
Closed -$13K
ALLO icon
1350
Allogene Therapeutics
ALLO
$735M
-11,350
Closed -$123K

Similar funds

Oppenheimer & Co's Q4 2022 Portfolio in Review

As of Q4 2022, Oppenheimer & Co held 1,464 positions worth $4.39B, up 2.8% from $4.27B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Oppenheimer & Co withdrew a net $190M in Q4 2022, closing 116 positions and reducing 644 holdings. Its most notable exit was State Street SPDR Portfolio Mortgage Backed Bond ETF, an estimated $8.22M position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Oppenheimer & Co opened a new position in State Street SPDR Portfolio S&P 500 Value ETF worth $5.18M.

  • Oppenheimer & Co's largest Q4 2022 buy was State Street SPDR Portfolio S&P 500 Value ETF: 133,272 shares worth $5.18M.
  • Oppenheimer & Co added most to iShares Treasury Floating Rate Bond ETF in Q4 2022, an estimated $5.9M increase.
  • Oppenheimer & Co's biggest Q4 2022 reduction was Berkshire Hathaway Class B, cutting an estimated $22.8M.
  • Oppenheimer & Co fully exited State Street SPDR Portfolio Mortgage Backed Bond ETF in Q4 2022, selling an estimated $8.22M.
  • Oppenheimer & Co's ten largest holdings make up 16% of its $4.39B portfolio in Q4 2022.
  • Oppenheimer & Co opened 104 new positions and closed 116 in Q4 2022.
  • Oppenheimer & Co's portfolio value rose 2.8% quarter-over-quarter to $4.39B.

Based on Oppenheimer & Co's 13F filing for Q4 2022, filed 8 Feb 2023.